News

Article

Clinical Quiz: ACG Guidelines on Acute Pancreatitis Management

Key Takeaways

  • Acute pancreatitis requires early identification and management to prevent complications and improve outcomes.
  • The condition's unpredictable nature stems from its heterogeneity and variable progression among patients.
SHOW MORE

Test your knowledge of the 2024 American College of Gastroenterology acute pancreatitis diagnosis and management guidelines with this clinical quiz!

HCPLive Clinical Quiz

HCPLive Clinical Quiz

As one of the most common diseases of the gastrointestinal tract leading to hospital admission in the US, early identification and management of acute pancreatitis is essential to prevent complications.

Owing to its heterogeneity and varying progression from patient to patient, acute pancreatitis is often unpredictable. Despite this, advancements in its management in recent years have led to a decrease in mortality. To summarize the available evidence about acute pancreatitis as it pertains to diagnosis, medical management, and evolving issues, in 2024, the American College of Gastroenterology released a clinical guideline on the management of acute pancreatitis.

Test your knowledge of the guidelines with this clinical quiz!

Which imaging modality is recommended for evaluating biliary pancreatitis in patients with acute pancreatitis?


Reference

Tenner S, Vege SS, Sheth SG, et al. American College of Gastroenterology Guidelines: Management of Acute Pancreatitis. The American Journal of Gastroenterology 119(3):p 419-437, March 2024. doi:10.14309/ajg.0000000000002645

Related Videos
Marlyn Mayo, MD: Improving Pruritus Management in PBC Care
Achieving Quick Responses in Sickle Cell Anemia With Early, Appropriate Hydroxyurea Dosing, with Abena Appiah-Kubi, MD, MPH
Steven W. Pipe, MD: Fitusiran With Anti-Thrombin Modulation Yields Effective Bleed Control, Reduces Infusions
Highlighting the Danger of SCI Progression during iTTP Remission, with Shruti Chaturvedi, MBSS, MS
Caroline Piatek, MD: Improving Patient-Reported Outcomes in PNH With Danicopan Add-on Therapy
Haydar Frangoul, MD: Preventing VOCs in People With Sickle Cell Disease With Exa-Cel Gene Editing Therapy
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
Andreas Kremer, MD, PhD, MHBA | Credit: AASLD
© 2024 MJH Life Sciences

All rights reserved.